Is Private Cataract Surgery Better Than NHS?

Posted October 19, 2025

TL;DR: Is Private Cataract Surgery Better Than NHS Cataract Surgery?

Private cataract surgery is not automatically a better operation than NHS cataract surgery. Excellent cataract surgery is performed throughout the NHS every day.

Private cataract care can, however, be better for an individual patient when what matters most is choosing their surgeon and being treated promptly. It can also provide greater control over the refractive outcome, access to a wider range of intraocular lenses and continuity with the same consultant throughout treatment.

The useful question is therefore not:

“Private or NHS: which one performs cataract surgery properly?”

Both can.

The better question is:

“Which pathway gives me the combination of clinical quality, choice, timing and visual outcome that matters most to me?”

For some patients, the NHS pathway is entirely appropriate. For others, private cataract surgery offers meaningful advantages.

If your main question is instead whether those advantages justify the financial cost, I have addressed that separately in Is It Worth Going Private for Cataract Surgery?

First: NHS Cataract Surgery Is Very Good

This should be said clearly.

I spent years working within the NHS, including five years as a Consultant Ophthalmic Surgeon at the Western Eye Hospital. I know the quality of cataract surgery that the NHS can deliver.

Cataract surgery itself is one of the most successful operations in medicine. Peter Desai, Anne Reidy, Darwin Minassian, George Vafidis and John Bolger demonstrated substantial improvements in visual function and quality of life following cataract surgery. ¹

Current NICE guidance describes cataract surgery as safe and highly effective. It recommends that the decision to operate should be based on the effect of the cataract on the individual’s vision and quality of life rather than an arbitrary visual acuity threshold. ²

The latest National Ophthalmology Database (NOD) audit also demonstrates how safe modern UK cataract surgery has become.

Across around 200 participating NHS departments, independent treatment centres and private practices, the national posterior capsule rupture rate has fallen to 0.69%. ³

So if somebody tells you that you have to pay privately because NHS cataract surgery is fundamentally unsafe or technically inferior, I do not think that is a fair representation of the evidence.

The differences lie elsewhere.

What Is the Difference Between Private Cataract Surgery and Cataract Surgery on the NHS?

There is no useful answer to the question until we define what better means.

A patient may be asking any of the following:

Is one pathway safer?
Will I see better afterwards?
Can I choose my surgeon?
Can I choose the lens implanted in my eye?
Can my astigmatism be corrected?
Can I reduce my dependence on glasses?
How quickly can I have surgery?
Who looks after me if something goes wrong?

When those questions are separated, the difference between NHS and private care becomes much clearer.

Cataract Surgery: NHS vs Private at a Glance

Core operation. NHS cataract surgery: established phacoemulsification. Private cataract surgery at Blue Fin Vision®: established phacoemulsification.
Cost to patient. NHS cataract surgery: free at the point of use. Private cataract surgery at Blue Fin Vision®: self-pay or insurance.
Timing. NHS cataract surgery: depends on local capacity. Private cataract surgery at Blue Fin Vision®: usually planned within weeks.
Named surgeon. NHS cataract surgery: care is delivered within an NHS surgical service. Private cataract surgery at Blue Fin Vision®: a named consultant is responsible for assessment, planning and surgery.
Lens choice. NHS cataract surgery: primarily a standard monofocal lens. Private cataract surgery at Blue Fin Vision®: premium monofocal, toric and presbyopia-correcting options are available where appropriate.
Spectacle independence. NHS cataract surgery: this is not usually the primary objective. Private cataract surgery at Blue Fin Vision®: spectacle independence can be an explicit refractive objective.
Astigmatism strategy. NHS cataract surgery: the availability of toric IOLs varies by NHS pathway, and alternative astigmatism-management strategies may be used. Private cataract surgery at Blue Fin Vision®: toric correction is available where clinically appropriate.
Continuity. NHS cataract surgery: care may involve different professionals. Private cataract surgery at Blue Fin Vision®: a consultant-led pathway provides continuity of care.
Outcome transparency. NHS cataract surgery: national NOD audit. Private cataract surgery at Blue Fin Vision®: the national benchmark plus Mr Hove’s own published audited outcomes.
Enhancement. NHS cataract surgery: this depends on clinical indication and the pathway. Private cataract surgery at Blue Fin Vision®: a defined Blue Fin Vision® Enhancement Policy applies to eligible patients.

That comparison explains why I resist saying that one system is simply “better”.

The operation may be excellent in either system. The degree of personalisation can be very different.

Is Private Cataract Surgery Safer Than NHS Surgery?

Not inherently.

Safety depends on the surgeon, the patient, the operating environment, preoperative assessment, surgical technique, infection prevention and the systems available when something unexpected occurs.

The building being private does not make an operation safe.

One of the most important examples comes from prevention of endophthalmitis, the rare but serious infection that can occur after cataract surgery.

The European Society of Cataract & Refractive Surgeons’ prospective randomised multicentre study involved more than 16,000 patients. It found that omission of intracameral cefuroxime was associated with approximately a five-fold increased risk of postoperative endophthalmitis. ⁴

That is evidence-based safety. It has nothing to do with whether the patient was sitting in a private waiting room or an NHS one.

What you should ask instead is: who is operating on me, what are their outcomes, what systems do they use to reduce risk, and what happens if something goes wrong?

Surgeon Choice Is One Area Where Private Care Can Be Better

For many patients, this is one of the clearest advantages of going private.

You can research the individual surgeon who will actually perform your procedure before committing to surgery. That means looking beyond reviews and asking about measurable things:

How much cataract surgery do they perform?
What is their experience with difficult or complex cases?
What is their posterior capsule rupture rate?
Do they publish their outcomes?
What experience do they have with the particular lens technology you are considering?
Who takes responsibility if the result is not what was intended?

I have performed more than 57,000 ophthalmic procedures, encompassing an enormous range of straightforward and complex eyes.

But volume should never be used as a substitute for outcomes. Since I advise patients to ask surgeons for their results, I think I should publish mine.

The Royal College of Ophthalmologists’ National Ophthalmology Database provides the principal national benchmarking system for cataract surgery.

Alexander Day, Paul Donachie, John Sparrow and Robert Johnston demonstrated the importance of posterior capsule rupture as a key cataract surgery outcome measure in the landmark NOD study. ⁵

I have published six consecutive years of audited cataract outcomes as full datasets.

My posterior capsule rupture rate runs at approximately 0.2%, compared with the latest national NOD figure of 0.69%. ³ Macular oedema occurred in 0.03% of 3,215 audited procedures.

Those figures do not mean I can guarantee complication-free surgery. Nobody can.

They mean that a patient can examine objective evidence about the surgeon they are considering rather than simply being told that the surgeon is “experienced”.

External recognition includes more than 550 verified Doctify reviews, Top Recommended status in the Spear’s 500 and inclusion in the Tatler Address Book.

This recognition sits alongside those audited outcomes rather than replacing them.

The network also operates under a single governance model. The same protocols, measurement pathways and follow-up standards apply at every site across London, Hertfordshire and Essex.

That degree of surgeon-specific choice and transparency is one of the areas in which private care can genuinely be better.

Lens Choice Is Probably the Biggest Clinical Difference

If your only objective is to remove your cataract and restore clear distance vision with a conventional monofocal lens, the gap between a good NHS pathway and a good private pathway may be relatively small.

If your objective is broader, particularly reducing your dependence on spectacles, the difference becomes much more significant.

Current NICE guidance states that multifocal intraocular lenses should not be offered as part of routine NHS cataract surgery. It also recognises that toric lenses reduce postoperative astigmatism, although their routine cost-effectiveness within the NHS remains debated. ²

Private cataract surgery allows suitable patients to consider a broader spectrum of lens technology.

This includes monofocal lenses where optical quality at a selected distance is the priority, toric lenses to correct clinically significant corneal astigmatism, and presbyopia-correcting lenses designed to provide useful vision across more than one distance.

Our IOL Lens Guide sets out the categories in more detail.

The evidence for some of these differences is substantial.

Line Kessel, Jens Andresen, Britta Tendal, Ditte Erngaard, Per Flesner and Jesper Hjortdal reviewed 13 randomised trials involving more than 1,400 eyes.

They found that toric intraocular lenses produced better uncorrected distance vision, greater spectacle independence and less residual astigmatism than non-toric approaches. ⁶

For presbyopia-correcting lenses, a Cochrane systematic review by Ranjan de Silva, Jennifer Evans, Vishal Kirthi, Mohammed Ziaei and Martin Leyland found that multifocal designs improve near vision and reduce spectacle dependence compared with monofocal lenses. There was a trade-off of increased haloes and glare in some patients. ⁷

That trade-off is exactly why a lens is not better because it is more expensive.

It is better only if its optical characteristics suit the patient receiving it. This requires assessment of the retina, optic nerve, cornea, ocular surface, astigmatism, pupil behaviour, occupation, driving requirements and expectations.

My view on this is also personal.

I researched multifocal intraocular lenses at Moorfields, I implant them professionally, and I chose trifocal lenses for both of my own eyes.

Living with the technology, including its real but tolerable glare and haloes, has made me more selective, not less, about recommending it.

I describe that experience in full, from both sides of the consultation desk, in Is It Worth Going Private for Cataract Surgery?

Is the Actual Surgery Better Privately?

The fundamentals of modern cataract surgery do not change simply because somebody is paying.

The cataract is removed and an intraocular lens is implanted. I would therefore be very wary of a private provider claiming that a particular machine automatically makes its operation superior.

A good example is femtosecond laser-assisted cataract surgery.

It sounds intuitively as though a laser must make cataract surgery better, but the evidence is more restrained.

The UK FACT randomised trial was conducted by Alexander Day, Jennifer Burr, Kate Bennett, Catey Bunce, Caroline Doré, Gary Rubin, Mayank Nanavaty, Kamaljit Balaggan and Mark Wilkins.

It found that femtosecond laser-assisted cataract surgery did not provide superior visual or patient-reported outcomes compared with conventional phacoemulsification. ⁸

Where technology genuinely earns its place is in measurement and consistency rather than marketing.

At Blue Fin Vision®, we use double biometry, where each eye is measured through more than one pathway to reduce the risk of a refractive surprise. We also work primarily with premium ZEISS lenses.

Where appropriate, I use 4-Minute Phaco™, a highly controlled, low-trauma technique in which the priority is control, safety and audited outcomes rather than speed.

Technology should serve the surgeon and the patient. It should not replace judgement.

Waiting Time Can Make Private Care Better, but It Is an Access Advantage, Not a Surgical One

NHS waiting times vary substantially between providers and regions.

The NHS constitutional standard remains that 92% of patients should wait no more than 18 weeks from referral to treatment.

Performance has improved substantially, but the latest available national data still show only around 65.6% of patients treated within 18 weeks. ⁹

Why does this matter?

The effect of cataract does not stop while somebody waits.

A systematic review by William Hodge, Tanya Horsley, David Albiani, Julie Baryla, Michel Belliveau, Ralf Buhrmann, Michael O’Connor, Jeremy Blair and Elizabeth Lowcock examined the consequences of waiting for cataract surgery.

It found that waits of more than six months are associated with vision loss, reduced quality of life and an increased rate of falls while patients wait. ¹⁰

That does not mean every cataract is urgent.

It does mean that if cataracts are stopping somebody driving, working or functioning independently, time has value.

Private surgery at Blue Fin Vision® can usually be arranged within weeks of completing assessment, subject to clinical suitability.

Continuity of Care Can Be Better Privately

This is less glamorous than lens technology, but I think patients underestimate its importance.

A cataract operation occupies only a few minutes. The treatment pathway is much longer.

It includes the initial assessment, the decision about whether surgery is appropriate, biometry, lens selection, consent, the surgery itself and postoperative review.

Occasionally, it also includes the management of an unexpected complication or refractive result.

At Blue Fin Vision®, the consultant remains responsible for the patient’s journey rather than the patient simply moving through disconnected parts of a system.

For many people, knowing who is responsible for their eyes has considerable value.

What Happens If the Result Is Not Perfect, or If There Is a Complication?

These are questions patients should ask before comparing providers.

The quality of a surgical service should not be judged solely by what happens when everything goes perfectly.

Modern cataract surgery is extremely accurate, but biological medicine does not produce identical results in every eye.

A patient may occasionally have residual short-sightedness, long-sightedness or astigmatism despite excellent surgery.

If spectacle independence was an agreed objective, the important question becomes what happens next and who pays for it.

Under the Blue Fin Vision® Enhancement Policy, which forms part of the Blue Fin Vision® Advantage, eligible self-pay and premium lens patients have enhancement fully covered within 24 months of the original procedure.

There is no cost-sharing or hidden top-up charge, and the terms are explained before treatment begins.

The full detail is set out in What Is Enhancement After Cataract Surgery?

The same principle applies to surgical complications.

Posterior capsule rupture is uncommon, but it remains one of the principal recognised intraoperative complications of cataract surgery.

If a complication such as retained or dropped lens material requires vitreoretinal intervention, Blue Fin Vision® has an established vitreoretinal service through which those cases are managed. There is no additional surgical fee to the patient.

A patient comparing private providers should therefore ask not merely, “What is your complication rate?” They should also ask, “What exactly happens to me if I am the complication?”

That question tells you a great deal about the quality of a surgical system.

Where Is NHS Cataract Surgery Better?

There is one area in which the NHS wins decisively.

Cost.

For an eligible NHS patient, treatment is free at the point of use.

Private cataract surgery represents a substantial personal expenditure, with current prices confirmed at consultation.

If you are happy with your NHS waiting time, do not mind which appropriate surgeon within the service performs your operation, are satisfied with a conventional monofocal strategy and are happy to wear spectacles afterwards, paying privately may add relatively little that matters to you.

In that situation, NHS surgery may not merely be adequate. It may be the more rational choice.

I would never advise somebody to spend thousands of pounds privately simply because private care exists.

Private treatment has to provide something that the individual patient actually values.

Should I Get Private Cataract Surgery or NHS Cataract Surgery?

For me, the answer becomes much clearer when several priorities coexist.

Private surgery is more likely to be the better pathway if:

You want to select the individual surgeon performing your operation.
You value treatment within a predictable timeframe.
You want your cataract surgery treated as a refractive procedure as well as cataract removal.
You have astigmatism that you would like addressed.
Reducing dependence on glasses is an important objective.
You want access to premium monofocal, toric or presbyopia-correcting lens technology where clinically appropriate.
You value continuity with a named consultant.
You want to examine the surgeon’s own published outcomes.
You want a clearly defined pathway for enhancement and complications.

None of these things means the NHS operation is bad.

They mean the private pathway is offering additional dimensions of care.

Why Published Outcomes Matter More Than the Word "Private"

Perhaps the most important point in this entire article is this: do not assume that private means better.

Private hospitals contain surgeons with different training, different case volumes and different outcomes, just as every healthcare system does.

The word private tells you how the treatment is funded. It does not tell you whether the surgeon is excellent.

That is why I believe outcomes should be published.

I publish my cataract surgery results over six consecutive years rather than selecting a single favourable period.

My approximately 0.2% posterior capsule rupture rate can then be compared directly with the current 0.69% national NOD benchmark. ³

That comparison tells a patient considerably more than the words “private cataract surgery”.

So, Is Private Cataract Surgery Better Than NHS?

Sometimes, but not for the simplistic reason people often assume.

Patients also ask: “Is it better to have cataracts done privately?”

NHS cataract surgery can be excellent. The fundamental operation does not suddenly become a different operation when it is performed privately.

Where private cataract surgery can be better is in the control surrounding the operation.

This includes who operates on you, when you are treated, which lens is implanted and what visual outcome you are aiming for.

It also includes how much spectacle independence matters, who follows you afterwards, what happens if something needs refining and what happens if there is a complication.

Having performed more than 57,000 ophthalmic procedures and having subsequently undergone intraocular lens surgery myself, I do not think of cataract surgery simply as removing a cloudy lens.

When I chose trifocal lenses for my own eyes, I was choosing the type of vision I wanted to live with afterwards.

That is the opportunity modern cataract surgery can offer.

For a patient who wants a straightforward monofocal cataract operation, is comfortable with their NHS pathway and is happy to use glasses afterwards, the NHS may be an excellent choice.

For a patient who wants to choose their surgeon, minimise waiting, explore advanced lens technology, optimise their refractive outcome and retain greater control over the entire pathway, private cataract surgery can genuinely be better.

The key word is not private. It is choice.

If your next question is whether those additional choices are worth paying for, read Is It Worth Going Private for Cataract Surgery?

If you would like to understand which options are appropriate for your own eyes, book a paid cataract consultation with the consultant-led Blue Fin Vision® team.

Appointments are available across London, Hertfordshire and Essex. The consultation fee reflects a detailed, independent clinical assessment rather than a sales appointment.

References

Desai P, Reidy A, Minassian DC, Vafidis G, Bolger J. Gains from cataract surgery: visual function and quality of life. Br J Ophthalmol. 1996;80(10):868-873. doi:10.1136/bjo.80.10.868. PMID: 8976696.
National Institute for Health and Care Excellence. Cataracts in adults: management. NICE guideline NG77. London: NICE; 2017. Available from: https://www.nice.org.uk/guidance/ng77
The Royal College of Ophthalmologists. National Ophthalmology Database Audit: Annual Report, cataract operations performed April 2023 to March 2024. London: RCOphth; 2025. Available from: https://www.nodaudit.org.uk/
Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007;33(6):978-988. doi:10.1016/j.jcrs.2007.02.032. PMID: 17531690.
Day AC, Donachie PHJ, Sparrow JM, Johnston RL. The Royal College of Ophthalmologists’ National Ophthalmology Database study of cataract surgery: report 1, visual outcomes and complications. Eye (Lond). 2015;29(4):552-560. doi:10.1038/eye.2015.3. PMID: 25679413.
Kessel L, Andresen J, Tendal B, Erngaard D, Flesner P, Hjortdal J. Toric intraocular lenses in the correction of astigmatism during cataract surgery: a systematic review and meta-analysis. Ophthalmology. 2016;123(2):275-286. doi:10.1016/j.ophtha.2015.10.002. PMID: 26601819.
de Silva SR, Evans JR, Kirthi V, Ziaei M, Leyland M. Multifocal versus monofocal intraocular lenses after cataract extraction. Cochrane Database Syst Rev. 2016;12:CD003169. doi:10.1002/14651858.CD003169.pub4. PMID: 27943250.
Day AC, Burr JM, Bennett K, Bunce C, Doré CJ, Rubin GS, Nanavaty MA, Balaggan KS, Wilkins MR; FACT Group. Femtosecond laser-assisted cataract surgery versus phacoemulsification cataract surgery (FACT): a randomized noninferiority trial. Ophthalmology. 2020;127(8):1012-1019. doi:10.1016/j.ophtha.2020.02.028. PMID: 32386810.
NHS England. Consultant-led Referral to Treatment (RTT) Waiting Times statistics, May 2026. Leeds: NHS England; 2026. Available from: https://www.england.nhs.uk/statistics/statistical-work-areas/rtt-waiting-times/
Hodge W, Horsley T, Albiani D, Baryla J, Belliveau M, Buhrmann R, O’Connor M, Blair J, Lowcock E. The consequences of waiting for cataract surgery: a systematic review. CMAJ. 2007;176(9):1285-1290. doi:10.1503/cmaj.060962. PMID: 17452662.

ABOUT THE AUTHOR

Mr Mfazo Hove
Consultant Ophthalmic Surgeon
MBChB MD FRCOphth CertLRS

Mr Mfazo Hove is a Consultant Ophthalmic Surgeon with experience spanning more than 57,000 procedures. He completed 6.5 years of specialist training at Moorfields Eye Hospital and served for five years as a consultant at the Western Eye Hospital, Imperial College Healthcare NHS Trust. He is the founder of Blue Fin Vision®, a consultant-led private ophthalmology practice operating across London, Essex, and Hertfordshire. His clinical expertise encompasses advanced cataract surgery, refractive lens replacement, laser vision correction, and implantable Collamer lenses (ICL).

A ZEISS Key Opinion Leader, Mr Hove is a respected international speaker with five invited engagements across seven cities in 2026:

ZEISS China tour (Changsha, Shanghai, and Hangzhou, April – ZEISS APAC User Meeting)
RCOphth Annual Congress – May – Manchester
ZEISS EMEA User Meeting (Istanbul)
ZEISS Lausanne User Meeting (Lausanne)
European Society of Cataract and Refractive Surgeons Annual Congress (ESCRS, London)

You may be interested in:

Get in Touch